GlaxoSmithKline Holdings Pty Ltd - Premium Company Report Australia

31-12-2012, 18 pages

GlaxoSmithKline Holdings Pty Ltd is a Proprietary Company that is ranked number 242 out of the top 2000 companies in Australia. The company generates the majority of its income from the Pharmaceutical Product Manufacturing in Australia industry.

In 2012 the company generated total revenue of $1,535,594,000 including sales and other revenue. In 2012 GlaxoSmithKline Holdings Pty Ltd had 1479 employees in Australia including employees from all subsidiaries under the company's control.

The Chief Executive of GlaxoSmithKline Holdings Pty Ltd is Mr Geoff McDonald whose official title is Vice President & General Manager Australia & New Zealand. The Chairman of GlaxoSmithKline Holdings Pty Ltd is Mr Geoff McDonald whose official title is Vice President & General Manager Australia & New Zealand.

GlaxoSmithKline Holdings Pty Ltd operates two main divisions:

Pharmaceuticals - includes prescription medicines such as antibiotics, antidepressant, gastrointestinal, dermatological, respiratory, cancer, cardiovascular medications and also vaccines for hepatitis A and B, diphtheria, tetanus and whooping cough, chicken pox and influenza

Consumer Healthcare - includes oral healthcare, over-the-counter medicines for pain management and smoking cessation and nutritional healthcare products

GlaxoSmithKline operates four manufacturing facilities in Australia:

Boronia, Victoria - Manufacture of pharmaceutical products
Ermington, New South Wales - Manufacture of consumer products
Latrobe, Tasmania - Supports production of opiates
Port Fairy, Victoria - Supports production of opiates

IBISWorld Premium Company Reports

The IBISWorld Company Premium Report offers a wealth of information on the top 550 companies. The detailed information and analysis in the Premium Report help you become better informed on all company activities. IBISWorld Company Premium Reports include: